Ligand Pharmaceuticals Inc - Company Profile
Powered by 
All the data and insights you need on Ligand Pharmaceuticals Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Ligand Pharmaceuticals Inc Strategy Report
- Understand Ligand Pharmaceuticals Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
The following section provides information on Ligand Pharmaceuticals Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Ligand Pharmaceuticals Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
John W. Kozarich, Ph.D.
Chairman Executive BoardDr. John W. Kozarich has been the Chairman of the company since 2007. He served as a Director of the company since 2003. Currently, he is also serving as the Distinguished Scientist of ActivX Biosciences. Prior to this, he served as the Chairman, the Director and President of ActivX Biosciences.
Todd C. Davis
Chief Executive Officer Executive BoardMr. Todd C. Davis has been the Chief Executive Officer since 2022. He serves as member of the Board since March 2007. Prior to this, he served Founder and Managing Partner of HealthCare Royalty Partners from 2006 to 2018. Earlier to this, he worked as partner for Apax Partners.
Tavo Espinoza
Chief Financial Officer Senior ManagementMr. Tavo Espinoza has been the Chief Financial Officer of the company since November 2022. Prior to this, he served as the Senior Vice President, Finance of the company. Previously, he served as the Senior Director, Finance at Receptos. Before that, he served as the Senior Director, Accounting at Illumina.
Matthew Korenberg
Chief Operating Officer; President Senior ManagementMr. Matthew Korenberg has been the Chief Operating Officer and President of the company since November 2022. Previously, he served as the Chief Financial Officer and Executive Vice President of Finance of the company since January 2018. Prior to this, he served as the Vice President of Finance and Chief Financial Officer of the company. He also served as the Chief Executive Officer of NeuroCircuit Therapeutics.
Andrew Reardon
Chief Legal Officer Senior ManagementMr. Andrew Reardon has been the Chief Legal Officer of the company since November 2022. Prior to this, he served as the Chief Legal Officer at HealthCare Royalty Management. Previously, he served as the Senior Associate at Willkie Farr & Gallagher.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer